XMED:LSE:LSE-Xtrackers MSCI Europe UCITS ETF 1C (USD)

ETF | Others |

Last Closing

USD 98.26

Change

+0.02 (+0.02)%

Market Cap

USD 4.56B

Volume

255.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+1.50 (+0.82%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-0.06 (-0.05%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.17 (+1.21%)

USD 572.76B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.20 (+1.11%)

USD 572.76B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.35 (-0.50%)

USD 266.08B
0QZO:LSE 0QZO

+0.25 (+0.27%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.32 (+1.02%)

USD 208.06B
0QZ3:LSE Qualcomm Inc.

+1.69 (+1.01%)

USD 202.26B
0R24:LSE Intel Corp.

+0.22 (+0.99%)

USD 196.14B

ETFs Containing XMED:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.71% 63% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.71% 62% D 63% D
Trailing 12 Months  
Capital Gain 17.46% 69% C- 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.46% 68% D+ 68% D+
Trailing 5 Years  
Capital Gain 45.74% 67% D+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 45.74% 65% D 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 9.96% 70% C- 72% C
Dividend Return 9.96% 69% C- 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 18.05% 39% F 54% F
Risk Adjusted Return 55.20% 68% D+ 79% B-
Market Capitalization 4.56B 94% A 76% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.